This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Shulin Wang: Innovator in IκB Kinase Research
Introduction
Shulin Wang is a notable inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the study of IκB kinase and its role in various disorders. His innovative work has led to the development of a functional assay that has potential therapeutic applications.
Latest Patents
Shulin Wang holds 1 patent for his invention titled "Assay for measuring IκB kinase activity and identifying IκB kinase modulators." This patent describes a functional assay for IκB kinase (IKK), which is crucial for understanding the proteasome and ubiquitin ligase pathways. The assay utilizes cells expressing an IκB-beta-lactamase fusion protein to screen for inhibitors of IKK. The inhibitors identified through this assay are particularly useful in treating NF-κB disorders, including immune and inflammatory conditions. The invention also encompasses cell lines, compounds identified through the assay, and methods for treating various disease states.
Career Highlights
Shulin Wang is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in the field of biochemistry. His work at this leading pharmaceutical company allows him to collaborate with other experts and contribute to the development of innovative treatments.
Collaborations
Shulin Wang collaborates with James R Burke, among others, to further enhance the research and development of therapeutic solutions. Their combined expertise fosters a productive environment for innovation.
Conclusion
Shulin Wang's contributions to the field of IκB kinase research exemplify the impact of innovative thinking in biochemistry. His patent and ongoing work at Bristol-Myers Squibb Company highlight the importance of scientific research in developing treatments for complex disorders.